Malaysia Approves Drug That Slows Alzheimer's by 8 Years
A newly approved Alzheimer's treatment in Malaysia can slow disease progression by more than eight years, giving patients precious extra time with their independence and loved ones. Unlike previous treatments that only managed symptoms, lecanemab actually changes how the disease progresses.
